Correlation Between Baron Health and Biotechnology Fund
Can any of the company-specific risk be diversified away by investing in both Baron Health and Biotechnology Fund at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Baron Health and Biotechnology Fund into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Baron Health Care and Biotechnology Fund Class, you can compare the effects of market volatilities on Baron Health and Biotechnology Fund and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Baron Health with a short position of Biotechnology Fund. Check out your portfolio center. Please also check ongoing floating volatility patterns of Baron Health and Biotechnology Fund.
Diversification Opportunities for Baron Health and Biotechnology Fund
0.79 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Baron and Biotechnology is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Baron Health Care and Biotechnology Fund Class in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biotechnology Fund Class and Baron Health is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Baron Health Care are associated (or correlated) with Biotechnology Fund. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biotechnology Fund Class has no effect on the direction of Baron Health i.e., Baron Health and Biotechnology Fund go up and down completely randomly.
Pair Corralation between Baron Health and Biotechnology Fund
Assuming the 90 days horizon Baron Health Care is expected to under-perform the Biotechnology Fund. But the mutual fund apears to be less risky and, when comparing its historical volatility, Baron Health Care is 1.32 times less risky than Biotechnology Fund. The mutual fund trades about -0.04 of its potential returns per unit of risk. The Biotechnology Fund Class is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest 7,011 in Biotechnology Fund Class on September 3, 2024 and sell it today you would lose (119.00) from holding Biotechnology Fund Class or give up 1.7% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Baron Health Care vs. Biotechnology Fund Class
Performance |
Timeline |
Baron Health Care |
Biotechnology Fund Class |
Baron Health and Biotechnology Fund Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Baron Health and Biotechnology Fund
The main advantage of trading using opposite Baron Health and Biotechnology Fund positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Baron Health position performs unexpectedly, Biotechnology Fund can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotechnology Fund will offset losses from the drop in Biotechnology Fund's long position.Baron Health vs. Vanguard Health Care | Baron Health vs. Vanguard Health Care | Baron Health vs. T Rowe Price | Baron Health vs. T Rowe Price |
Biotechnology Fund vs. Vanguard Health Care | Biotechnology Fund vs. Vanguard Health Care | Biotechnology Fund vs. T Rowe Price | Biotechnology Fund vs. T Rowe Price |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |